Peter Attia· MD
nowadays for higher risk ones we add a second anti-h er drug called pusab or petta
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
nowadays for higher risk ones we add a second anti-h er drug called pusab or petta
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
where it has gone from one of the most feared types of breast cancer to one of the most successfully treated types of breast cancer
nowadays for higher risk ones we add a second anti-er to drug called pusab or petta now interestingly we're still giving chemotherapy with those anti- heru drugs
We've completely flipped the outcomes for herto positive breast cancer where it has gone from one of the most feared types of breast cancer to one of the most successfully treated types of breast cancer